A detailed history of Cipher Capital LP transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Cipher Capital LP holds 1,680 shares of NBIX stock, worth $197,299. This represents 0.11% of its overall portfolio holdings.

Number of Shares
1,680
Previous 10,203 83.53%
Holding current value
$197,299
Previous $1.34 Million 82.81%
% of portfolio
0.11%
Previous 0.44%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$130.4 - $143.74 $1.11 Million - $1.23 Million
-8,523 Reduced 83.53%
1,680 $231,000
Q4 2023

Feb 14, 2024

BUY
$106.07 - $132.76 $361,804 - $452,844
3,411 Added 50.22%
10,203 $1.34 Million
Q3 2023

Nov 14, 2023

BUY
$94.02 - $117.1 $638,583 - $795,343
6,792 New
6,792 $764,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.2B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Cipher Capital LP Portfolio

Follow Cipher Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cipher Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Cipher Capital LP with notifications on news.